Anti-HLA class I antibodies activate endothelial cells and promote chronic rejection

Transplantation

Volumn 79, Issue 3 SUPPL., 2005, Pages

  Jin, Yi Ping ^a   Jindra, Peter T ^a   Gong, Ke Wei ^a   Lepin, Eric J ^a   Reed, Elaine F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CYCLIN E; FOCAL ADHESION KINASE; HLA ANTIBODY; HLA ANTIGEN CLASS 1; MITOGEN ACTIVATED PROTEIN KINASE; PAXILLIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN 14 3 3; PROTEIN BAD; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN CDC42; PROTEIN KINASE B; RAC PROTEIN; RHO FACTOR; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; WORTMANNIN;

ARTERIOSCLEROSIS; CELL PROLIFERATION; CHRONIC GRAFT REJECTION; CONFERENCE PAPER; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ENDOTHELIUM, VASCULAR; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; ISOANTIBODIES; SIGNAL TRANSDUCTION;

EID: 14344259121     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000153293.39132.44     Document Type: Conference Paper

References (17)

1. Bian H, Harris PE, Mulder A, Reed EF. Anti-HLA antibody ligation to HLA class I molecules expressed by endothelial cells stimulates tyrosine phosphorylation, inositol phosphate generation, and proliferation. Hum Immunol 1997; 53: 90.
2. Bian H, Harris PE, Reed EF. Ligation of HLA class I molecules on smooth muscle cells with anti-HLA antibodies induces tyrosine phosphorylation, fibroblast growth factor receptor expression and cell proliferation. Int Immunol 1998; 10: 1315.
3. Bian H, Reed EF. Alloantibody-Mediated Class I Signal Transduction in Endothelial Cells and Smooth Muscle Cells: Enhancement by IFN-gamma and TNF-alpha. J Immunol 1999; 163: 1010.
4. Bian H, Reed EF. Anti-HLA antibodies transduce proliferative signals in endothelial cells and smooth muscle cells. Transplant Proc 1999; 31: 1924.
5. Harris PE, Bian H, Reed EF. Induction of high affinity fibroblast growth factor receptor expression and proliferation in human endothelial cells by anti-HLA antibodies: a possible mechanism for transplant atherosclerosis. J Immunol 1997; 159: 5697.
6. Reed EF. Signal transduction via MHC class I molecules in endothelial and smooth muscle cells. Crit Rev Immunol 2003; 23: 109.
7. Jin YP, Singh RP, Du ZY, Rajasekaran AK, Rozengurt E, Reed EF. Ligation of HLA class I molecules on endothelial cells induces phosphorylation of Src, paxillin and focal adhesion kinase in an actin dependent manner. J Immunol 2002; 168: 5415.
8. Lowell CA. Src-family kinases: rheostats of immune cell signaling. Mol Immunol 2004; 41: 631.
9. Schaller MD. Biochemical signals and biological responses elicited by the focal adhesion kinase. Biochim Biophys Acta 2001; 1540: 1.
10. Schlaepfer DD, Mitra SK. Multiple connections link FAK to cell motility and invasion. Curr Opin Genet Dev 2004; 14: 92.
11. Parsons JT. Focal adhesion kinase: the first ten years. J Cell Sci 2003; 116: 1409.
12. Lepin EJ, Jin YP, Barwe SP, Rozengurt E, Reed EF. HLA class I signal transduction is dependent on Rho GTPase and ROK, In press.
13. Jin YP, Fishbein MC, Said JW, et al. Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells. Hum Immunol 2004; 65: 291.
14. Brazil DP, Hemmings BA. Ten years of protein kinase B signaling: a hard Akt to follow. Trends Biochem Sci 2001; 26: 657.
15. Datta SR, Brunet A, Greenberg ME. Cellular survival: a play in three Akts. Genes Dev 1999; 13: 2905.
16. Yano S, Tokumitsu H, Soderling TR. Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway. Nature 1998; 396: 584.
17. Nath N, Bian H, Reed EF, Chellappan SP. HLA Class I-Mediated Induction of Cell Proliferation Involves Cyclin E-Mediated Inactivation of Rb Function and Induction of E2F Activity. J Immunol 1999; 162: 5351.